The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders. 2023

Sahar Alijanpour, and Mohammad Miryounesi, and Soudeh Ghafouri-Fard
Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS). Excitatory amino acid transporters (EAATs) have important roles in the uptake of glutamate and termination of glutamatergic transmission. Up to now, five EAAT isoforms (EAAT1-5) have been identified in mammals. The main focus of this review is EAAT2. This protein has an important role in the pathoetiology of epilepsy. De novo dominant mutations, as well as inherited recessive mutation in this gene, have been associated with epilepsy. Moreover, dysregulation of this protein is implicated in a range of neurological diseases, namely amyotrophic lateral sclerosis, alzheimer's disease, parkinson's disease, schizophrenia, epilepsy, and autism. In this review, we summarize the role of EAAT2 in epilepsy and other neurological disorders, then provide an overview of the therapeutic modulation of this protein.

UI MeSH Term Description Entries
D008322 Mammals Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young. Mammalia,Mammal
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D018698 Glutamic Acid A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM. Aluminum L-Glutamate,Glutamate,Potassium Glutamate,D-Glutamate,Glutamic Acid, (D)-Isomer,L-Glutamate,L-Glutamic Acid,Aluminum L Glutamate,D Glutamate,Glutamate, Potassium,L Glutamate,L Glutamic Acid,L-Glutamate, Aluminum
D027342 Excitatory Amino Acid Transporter 2 A glutamate plasma membrane transporter protein found in ASTROCYTES and in the LIVER. EAAT-2 Excitatory Amino Acid Transporter,EAAT2 Neurotransmitter Transporter,GLT-1 Transport Protein,GluT-1 Glutamate Transporter,SLC1A2 Transporter,EAAT 2 Excitatory Amino Acid Transporter,GLT 1 Transport Protein,GluT 1 Glutamate Transporter,Glutamate Transporter, GluT-1,Neurotransmitter Transporter, EAAT2,Transport Protein, GLT-1,Transporter, SLC1A2

Related Publications

Sahar Alijanpour, and Mohammad Miryounesi, and Soudeh Ghafouri-Fard
January 2019, Frontiers in pharmacology,
Sahar Alijanpour, and Mohammad Miryounesi, and Soudeh Ghafouri-Fard
April 2001, Forensic science international,
Sahar Alijanpour, and Mohammad Miryounesi, and Soudeh Ghafouri-Fard
October 2011, Journal of cellular physiology,
Sahar Alijanpour, and Mohammad Miryounesi, and Soudeh Ghafouri-Fard
October 2010, The Journal of biological chemistry,
Sahar Alijanpour, and Mohammad Miryounesi, and Soudeh Ghafouri-Fard
March 2020, The Journal of biological chemistry,
Sahar Alijanpour, and Mohammad Miryounesi, and Soudeh Ghafouri-Fard
October 2008, The Journal of veterinary medical science,
Sahar Alijanpour, and Mohammad Miryounesi, and Soudeh Ghafouri-Fard
August 2022, Nature communications,
Sahar Alijanpour, and Mohammad Miryounesi, and Soudeh Ghafouri-Fard
May 1998, Neuroreport,
Sahar Alijanpour, and Mohammad Miryounesi, and Soudeh Ghafouri-Fard
June 2017, Journal of medicinal chemistry,
Copied contents to your clipboard!